JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
05/11/25 - 17:46
Diasorin’s Board of Directors approves results for the first 9 months of 2025. FY 2025 Guidance revised (255.77 KB)
31/07/25 - 16:22
Revenue Growth and Margin Expansion in H1 2025. FY 2025 Guidance Confirmed (238.17 KB)
06/05/25 - 17:41
Revenue growing +8% and EBITDA margin at 34%: Q1 Results confirm FY 2025 Guidance (268.56 KB)
14/03/25 - 16:29
The Board of Directors of Diasorin SpA approves FY2024 Results with revenues and net profit in expansion compared to Previous Year; Proposed Ordinary Dividend of € 1.20 per share (239.79 KB)
14/11/14 - 1:00
The Board of Directors approves the results for Q3'14 (785.42 KB)
01/08/14 - 2:00
The Board of Directors approves the results for H1'14 (812.25 KB)
22/07/14 - 2:00
DIASORIN CONFIRMS ITS ELIGIBILITY FOR THE PEA-PME (148.49 KB)
09/05/14 - 2:00
The Board of Directors approves the results for Q1'14 (573.05 KB)
23/04/14 - 2:00
Shareholders' meeting approves FY Results 2013 (107.65 KB)
06/03/14 - 1:00